Repaglinide Tablet
Product Images NDC 60687-560

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 60687-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aur06710

Aur06710
Repaglinide 1 mg oral tablet, round and light yellow, imprinted with "H" on one side and "11" on the other, manufactured by American Health Packaging.*
FDA Label Image

1 mg Repaglinide Tablet Blister (Blister)

1 mg Repaglinide Tablet Blister (Blister)
Repaglinide 1 mg oral tablets by American Health Packaging. The image shows multiple small labels each listing the product name, strength (1 mg), form (tablet, USP), a barcode, and placeholder text for expiry date and lot number. The labeler information and NDC 60687-560 are also visible.*
FDA Label Image

1 mg Repaglinide Tablets Carton (Carton)

1 mg Repaglinide Tablets Carton (Carton)
Repaglinide 1 mg tablets by American Health Packaging, presented in a blister pack of 30 tablets (3 x 10). The label includes dosage form (tablet), prescription status (Rx Only), storage instructions, and safety warnings. NDC 60687-560-21 is displayed along with a barcode.*
FDA Label Image

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Figure 1)

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Figure 1)
A line graph showing the percentage change in HbA1c over 24 treatment weeks. It compares three groups: Repaglinide plus Pioglitazone, Repaglinide alone, and Pioglitazone alone. The x-axis represents treatment weeks from 0 to 24, and the y-axis shows change in HbA1c percentage from 0 to -2%. The combination group shows the greatest decrease in HbA1c over time.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of repaglinide, showing its molecular framework including aromatic rings, carbon chains, and functional groups such as ketone and carboxylic acid moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.